25.11.2019 – 10:13 Jennewein Biotechnologie GmbHJennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer of human milk oligosaccharides (HMOs), announces that the U.S. Food and Drug Administration (FDA) issued a "no question" response letter to Jennewein's supplement of its GRAS Notice GRN571, thereby acknowledging that the ... more
25.11.2019 – 10:02 Jennewein Biotechnologie GmbHJennewein Biotechnologie sues Glycom for patent infringement in Denmark Rheinbreitbach (ots) - Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk oligosaccharides (HMOs) cost efficiently in an industrial scale since 2005 to make these special sugars available for affordably priced infant formula and other uses in food. Jennewein Biotechnologie was the first commercial vendor of HMOs, and brought the ... more
